Neural Mechanisms and Predictors of an Ultra-Brief Suicide Prevention Strategy

超简短自杀预防策略的神经机制和预测因子

基本信息

  • 批准号:
    10198354
  • 负责人:
  • 金额:
    $ 64.84万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-05-01 至 2026-04-30
  • 项目状态:
    未结题

项目摘要

Close to 45,000 Americans die from suicide each year and rates have been steadily rising for the last two decades. There is an urgent need for better access to effective suicide prevention strategies that are highly transportable across medical settings. Data from the current team indicates that a single session of crisis response planning (CRP) reduces suicide behavior by 76%; however, it is unknown how CRP works, and for whom, curtailing strategy optimization and widespread implementation. Clinicians speculate that CRP works by strengthening emotion regulation capabilities and reducing stress reactivity; however, this hypothesis has never been tested and no prior study has identified neural mechanisms and predictors of changes in suicide risk following intervention. Related, there are no objective brain-based markers of ‘reduced’ suicide risk to inform clinical decision making and guide high-risk patients to needed services. To address these gaps and ultimately improve suicide prevention efforts we seek to identify brain-based mechanisms and predictors of changes in suicidality following a single session of CRP in a cohort of adults with active suicidal intent. We will take an innovative and comprehensive approach by probing stress reactivity and emotion regulation neural circuits in the context of a clinical trials design. Specifically, we will combine sources of information and simultaneously collect assessments of neural function, psychophysiology (i.e., startle eyeblink potentiation), behavior and self-report during functional magnetic resonance imaging (fMRI) before (Time 1) and after (Time 2) randomization to a single, one-hour session of CRP or standard suicide risk management (control). A small group of volunteers with no history of suicide ideation or intent will be included for comparison. Using ecological momentary assessment (EMA) technology, acute changes in suicidality following intervention will be assessed twice daily for the first week. Monthly online clinical surveys will also be administered, and at 6-months post- intervention, the entire multimodal assessment battery will be re-administered (Time 3). This innovative, multilayered, longitudinal design will allow for a well-controlled test of how a single session of CRP acutely changes suicide risk (Aim 1). The study will also address whether the acute effects of CRP are sustained over time and how neural function influences long-term changes in suicidality (Aim 2). Lastly, we will conduct sophisticated analyses to integrate data across ‘units of analysis’ and functional domains to test whether there are reliable prognostic indicators of CRP intervention success (Aim 3). Findings from this study will provide critical new knowledge regarding how an ultra-brief session of CRP works and for whom, while uncovering a mechanistic signal of reduced suicide risk. In addition, consistent with the mission of the NIMH BRAINS program, the award will facilitate the launch of the PI’s innovative translational program of research and pave the way for a series of large-scale studies aimed at identifying neurobiological targets for resolving suicide risk and testing whether interventions with effective target engagement can enhance suicide prevention outcomes.
每年有近4.5万美国人死于自杀,最近两年自杀率一直在稳步上升。 几十年迫切需要更好地获得有效的自杀预防策略, 可在医疗环境中移动。当前团队的数据表明, 反应计划(CRP)减少了76%的自杀行为;然而,CRP是如何工作的, 谁,削减战略优化和广泛实施。临床医生推测CRP的作用机制是 增强情绪调节能力,降低应激反应;然而,这一假设从未被证实。 之前的研究还没有确定神经机制和自杀风险变化的预测因素 干预后。相关的,没有客观的基于大脑的标记物来告知“降低”的自杀风险 临床决策和指导高风险患者所需的服务。为了弥补这些差距, 改善自杀预防工作,我们寻求确定大脑为基础的机制和变化的预测因素, 一组有主动自杀意图的成年人在单次CRP治疗后的自杀倾向。我们将采取一个 通过探索压力反应和情绪调节神经回路, 临床试验设计的背景。具体来说,我们将联合收割机的信息来源,同时 收集神经功能,心理生理学(即,惊吓眨眼增强),行为 在功能性磁共振成像(fMRI)之前(时间1)和之后(时间2)进行自我报告 随机分配到一个单一的,一个小时的CRP或标准自杀风险管理(对照)。一个小 一组没有自杀意念或意图的志愿者将被包括用于比较。运用生态 瞬时评估(EMA)技术,将评估干预后自杀倾向的急性变化 第一周每天两次每月还将进行在线临床调查,并在6个月后, 干预后,将重新进行整个多模式评估组合(时间3)。这一创新, 多层纵向设计将允许一个良好的控制测试如何一个单一的会议CRP急性 改变自杀风险(目标1)。该研究还将探讨CRP的急性效应是否持续超过 时间和神经功能如何影响自杀倾向的长期变化(目的2)。最后,我们将进行 复杂的分析,以整合跨“分析单元”和功能域的数据, 是CRP干预成功的可靠预后指标(目标3)。这项研究的结果将提供 关于CRP的超简短会议如何工作以及为谁工作的关键新知识,同时揭示了 降低自杀风险的机械信号。此外,与NIMH脑计划的使命一致, 该奖项将促进PI创新转化研究计划的启动,并为 一系列旨在确定解决自杀风险的神经生物学目标和测试的大规模研究 是否有效的目标参与干预可以提高自杀预防的结果。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Stephanie Gorka其他文献

Stephanie Gorka的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Stephanie Gorka', 18)}}的其他基金

Orexin Receptor Antagonists as Modulators of Threat Sensitivity in individuals with Alcohol Use Disorder
食欲素受体拮抗剂作为酒精使用障碍患者威胁敏感性的调节剂
  • 批准号:
    10704154
  • 财政年份:
    2022
  • 资助金额:
    $ 64.84万
  • 项目类别:
Orexin Receptor Antagonists as Modulators of Threat Sensitivity in individuals with Alcohol Use Disorder
食欲素受体拮抗剂作为酒精使用障碍患者威胁敏感性的调节剂
  • 批准号:
    10590414
  • 财政年份:
    2022
  • 资助金额:
    $ 64.84万
  • 项目类别:
Trauma and Neurobiological Threat Reactivity as Risk Factors for Alcohol Abuse in Youth
创伤和神经生物学威胁反应作为青少年酗酒的危险因素
  • 批准号:
    10582520
  • 财政年份:
    2021
  • 资助金额:
    $ 64.84万
  • 项目类别:
Neural Mechanisms and Predictors of an Ultra-Brief Suicide Prevention Strategy
超简短自杀预防策略的神经机制和预测因子
  • 批准号:
    10400127
  • 财政年份:
    2021
  • 资助金额:
    $ 64.84万
  • 项目类别:
Neural Mechanisms and Predictors of an Ultra-Brief Suicide Prevention Strategy
超简短自杀预防策略的神经机制和预测因子
  • 批准号:
    10605345
  • 财政年份:
    2021
  • 资助金额:
    $ 64.84万
  • 项目类别:
Trauma and Neurobiological Threat Reactivity as Risk Factors for Alcohol Abuse in Youth
创伤和神经生物学威胁反应作为青少年酗酒的危险因素
  • 批准号:
    10368089
  • 财政年份:
    2021
  • 资助金额:
    $ 64.84万
  • 项目类别:
Brain-Behavior Reactivity to Threat and Alcohol Abuse Risk in Young Adults
年轻人对威胁和酒精滥用风险的大脑行为反应
  • 批准号:
    10094300
  • 财政年份:
    2017
  • 资助金额:
    $ 64.84万
  • 项目类别:
Brain-Behavior Reactivity to Threat and Alcohol Abuse Risk in Young Adults
年轻人对威胁和酒精滥用风险的大脑行为反应
  • 批准号:
    9314793
  • 财政年份:
    2017
  • 资助金额:
    $ 64.84万
  • 项目类别:
Response to Unpredictable Threat in Alcohol Dependence and Panic Disorder
对酒精依赖和恐慌症中不可预测的威胁的反应
  • 批准号:
    8784054
  • 财政年份:
    2013
  • 资助金额:
    $ 64.84万
  • 项目类别:
Response to Unpredictable Threat in Alcohol Dependence and Panic Disorder
对酒精依赖和恐慌症中不可预测的威胁的反应
  • 批准号:
    8647386
  • 财政年份:
    2013
  • 资助金额:
    $ 64.84万
  • 项目类别:

相似海外基金

Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 64.84万
  • 项目类别:
    Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 64.84万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 64.84万
  • 项目类别:
    Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 64.84万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 64.84万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 64.84万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 64.84万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 64.84万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 64.84万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
  • 批准号:
    2244994
  • 财政年份:
    2023
  • 资助金额:
    $ 64.84万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了